Introduction {#Sec1}
============

The antiviral activities of isatin derivatives have been widely reported, especially their action against pox virus \[[@CR1]\], vaccinia \[[@CR2]\], rhino virus \[[@CR3]\], Moloney leukemia virus \[[@CR4]\], and SARS virus \[[@CR5]\]. Previous works have also reported the inhibitory activity of isatin-thiosemicarbazones and isatin derivatives on HIV replication \[[@CR6]--[@CR8]\]. In addition, methisazone (an isatin-thiosemicarbazone) plays an important role as a prophylactic agent against several viral diseases \[[@CR9]\]. There has been increasing interest in recent years concerning the introduction of fluorine into organic compounds \[[@CR10], [@CR11]\]. Incorporation of one or several fluorine atoms into an organic molecule can improve the pharmacokinetic and pharmacodynamic properties such as absorption, tissue distribution, secretion, the route and rate of biotransformation, toxicology, bioavailability, metabolic stability, and lipophilicity \[[@CR12], [@CR13]\]. Many of the compounds containing a fluorine atom have a significant therapeutic impact. Fluorinated isatin derivatives have become a focus in the development of new biologically active compounds \[[@CR14]\].

In view of these observations and as a continuation of our effort in developing broad-spectrum chemotherapeutics \[[@CR15]--[@CR18]\], we report the preparation of some newer fluorinated iminoisatin derivatives in the hope of obtaining better antiviral drugs without side effects.

Results and discussion {#Sec2}
======================

Chemistry {#Sec3}
---------

In the present investigation, the reactivity of 5-fluoroisatin (**1**) towards some different types of nitrogen nucleophile was studied with the objective of obtaining biologically active compounds. Thus, reaction of 5-fluoroisatin with 3-amino-2-thioxothiazolidin-4-one afforded the corresponding Schiff's base **2**. Reaction of **1** with a fluorinated aromatic amine, 2-amino-*N*-\[3-(trifluoromethyl)phenyl\]benzamide, afforded the corresponding Schiff's base **3**. The spectral data of the isolated products were in complete agreement with their structures. The aromatic signals were observed in all cases as multiplets for the 5-fluorisatin protons owing to F--H and H--H couplings. The structures of **2** and **3** were assigned the basis of analytical and spectral data. The IR spectrum of **2** displayed absorption bands at *ν* = 3,238 (NH), 1,700, 1,668 (C=O, amidic C=O) cm^−1^. Its ^1^H NMR spectrum exhibited a sharp singlet signal at *δ* = 5.80 ppm assigned to CH~2~ protons, three signals at 6.87, 8.60, and 7.30 ppm owing to indole protons, and a D~2~O-exchangeable singlet signal at 11.40 ppm due to NH proton.

Hydrazone derivative **4** was prepared according to a literature procedure by treatment of 5-fluoroisatin (**1**) with hydrazine hydrate in ethanol \[[@CR19]\].

It was of interest to synthesize some new sulfonamide derivatives. Thus, sulfonamide derivatives **5a**--**5c** were prepared by heating the hydrazone **4** with sulfonyl chloride derivatives (namely methanesulfonyl chloride, benzenesulfonyl chloride, or 4-methylbenzenesulfonyl chloride) in dioxane containing a catalytic amount of triethylamine. Sulfonamide derivative **5c** was prepared previously by the reaction of 5-fluoroisatin with tolylsulfonylhydrazine and reported in a patent \[[@CR20]\]. The IR spectrum of **5a** revealed absorption bands at 3,178 and 3,106 cm^−1^ due to two NH groups, and a band near 1,660 cm^−1^ that was attributed to the carbonyl group. Its ^1^H NMR spectrum revealed singlet signals at 2.83 ppm due to CH~3~ protons beside two singlet signals in the region of 10.68 and 11.80 ppm due to two NH groups. The mass spectroscopic measurements of **7c** showed *m*/*z* = 333 (M^+^, 5.8) which indicates structure **5**.

Interaction of the hydrazone derivative **4** with trifluoroacetic anhydride afforded the corresponding hydrazone derivative **6**. The spectral data of the isolated product was in complete agreement with its structure. The IR spectrum of **6** revealed absorption bands at 3,255 and 3,107 cm^−1^ (NH) and 1,696 and 1,661 cm^−1^ (C=O).

In this study, the reactivity of hydrazone **4** towards isothiocyanate derivatives was investigated. Thus, when hydrazone **4** was left to react with different isothiocyanate derivatives in ethanol, the corresponding thiosemicarbazone derivatives **7a**--**7f** were obtained. Thiosemicarbazone derivatives **7a**--**7f** were prepared previously by treatment of 5-fluoroisatin with different *N*-substituted thiosemicarbazide derivatives \[[@CR21]\]. We have extended our synthetic program to utilize structures **7a**--**7f** as the key starting materials for alkylation with chloroacetone in ethanol containing fused sodium acetate to furnish the corresponding thiazole derivatives **8a**--**8f**. The IR spectrum of compound **8a** revealed absorption bands at 3,212 and 1,675 cm^−1^ characteristic for NH and C=O groups, respectively. Its ^1^H NMR spectrum revealed signals at 1.76 and 2.76 ppm due to two methyl groups and at 5.85 ppm due to the CH proton. Moreover the mass spectrum of compound **8c** showed the molecular ion peak at 332 (M^+^, 84.2 %) (Scheme [1](#Sch1){ref-type="fig"}).

In continuation with our work in this area, we decided to prepare and evaluate the biological activity of some new isatin thiocarbohydrazone derivatives. When the 5-fluoroisatin was reacted with thiocarbohydrazide, 5-fluoroisatin thiocarbohydrazone (**9**) was obtained. The IR spectrum showed absorption bands at 3,270, 3,160, and 3,106 cm^−1^, corresponding to NH~2~ and NH functions. The ^1^H NMR spectrum revealed D~2~O-exchangeable signals at 2.51, 4.92, 10.40, and 12.54 ppm assignable to NH~2~ and NH protons. Thiocarbohydrazone **9** was used as a starting material in the synthesis of different types of isatin thiocarbohydrazone derivatives. Thus, when compound **9** was condensed with some selected aldehydes, the corresponding thiocarbohydrazones **10a**--**10e** were obtained in good yield. The structure of **10** was established on the basis of its spectral data beside its independent synthesis via the reaction of *N*-thiocarbohydrazones with 5-fluoroisatin which afforded products identical in all respects with those obtained previously.

When **9** was condensed with 5-fluoroisatin, the corresponding bis-isatin thiocarbohydrazone **11** was obtained in quantitative yield. Finally, trifluoroacyl derivative **12** was prepared by the reaction of thiocarbohydrazone derivative **9** with trifluoroacetic anhydride. The structure of **11** was based of analytical and spectral data. Thus the mass spectrum of this product showed the molecular ion peak at *m*/*z* = 400 (M^+^, 12.6), with a base peak at 136. The IR spectrum revealed absorption bands at 3,256, 3,212, and 3,187 cm^−1^ (NH) and 1,667 cm^−1^ (C=O). The ^1^H NMR spectrum revealed signals at 7.10--7.64 ppm due to the aromatic protons. The IR spectrum of compound **12** showed a broad absorption band around 3,340--3,210 cm^−1^ due to NH groups besides two carbonyl absorption bands at 1,697 and 1,670 cm^−1^. Its ^1^H NMR spectrum revealed four D~2~O-exchangeable signals at 10.87, 11.45, 12.12, and 14.34 ppm due to four NH protons (Scheme [2](#Sch2){ref-type="fig"}).

Biological activity {#Sec4}
-------------------

### Cytotoxicity and antiviral activities {#Sec5}

The selected synthesized isatin derivatives **7a**--**7e**, **10a**--**10e**, and **11** were evaluated for their inhibitory effect on the replication of vesicular stomatitis virus (VSV) as well as cytotoxicity evaluation in Vero clone CCL-81 cell lines. Evaluation of the antiviral activity of isatin derivatives and interferon as standard was determined according to Shinji's method \[[@CR22]\] and the results are summarized in Table [1](#Tab1){ref-type="table"}.Table 1Cytotoxicity and antiviral activity for the selected compounds![](706_2013_1034_Figb_HTML.gif){#d29e672}CompoundR*IC* ~50~/μmol cm^−3^Antiviral activityVirus titer log~10~Virus titer difference logEffectControl----6.28----**7a**--CH~3~12.86.430.15Increased**7b**--CH~2~CH~3~25.36.330.05Increased**7c**--CH~2~CH=CH~2~24.85.400.88Decreased**7d**--(CH~2~)~3~CH~3~24.95.490.76Decreased**7e**![](706_2013_1034_Figc_HTML.gif){#d29e860}5.76.400.20Increased**10a**![](706_2013_1034_Figd_HTML.gif){#d29e885}23.66.490.21Increased**10b**![](706_2013_1034_Fige_HTML.gif){#d29e910}1.05.380.90Decreased**10c**![](706_2013_1034_Figf_HTML.gif){#d29e935}3.05.570.68Decreased**10d**![](706_2013_1034_Figg_HTML.gif){#d29e960}1.56.590.31Increased**10e**![](706_2013_1034_Figh_HTML.gif){#d29e985}12.26.000.28Decreased**11**![](706_2013_1034_Figi_HTML.gif){#d29e1011}12.66.110.17DecreasedInterferon4.401.88Decreased

Certain aspects of the structure--activity relationships for these compounds can be more clearly highlighted using the general structures provided in Table [1](#Tab1){ref-type="table"}. From the tabulated data, it was found that six compounds showed activities against the tested virus. In the Vero clone CCL-81 cell lines, compound **7c**, which has an allyl moiety, was found to be the most active among compounds **7** against replication of VSV with a log virus titer difference of 0.88; when the allyl moiety of this compound was replaced by an *n*-butyl moiety, as in the case of compound **7d**, the log virus titer difference decreased to 0.76. No positive activities were noticed in the other tested samples among the series of tested structure. Compound **10b**, which has a 4-fluorophenyl moiety, showed the highest activity among compounds **10** against replication of VSV with a log virus titer difference of 0.90; when this moiety was replaced by a 4-dimethylphenyl moiety, as in the case of compound **10c**, the activity decreased and showed a log virus titer difference of 0.68. Compounds **10e** and **11** exhibited weak activity, whereas the other tested compounds showed no positive antiviral activity. In pharmacological terms, the presence of the 4-fluorophenyl moiety on the skeleton of structure **10** may be directly responsible for its antiviral activity, whereas the presence of the allyl moiety in compound **7c** makes it a promising antiviral agent.

Conclusion {#Sec6}
==========

A new series of 5-fluoroisatin derivatives was synthesized. The antiviral screening of some selected compounds showed good inhibitory activities as antiviral agents. Among the tested compounds, *N* ~1~-(5-fluoro-2-oxoindolin-3-ylidene)-*N* ~4~-(*p*-fluoro- (or *p*-dimethylamino)benzylidene)thiocarbohydrazone and *N*-allyl (or *n*-butyl)-2-(5-fluoro-2-oxoindolin-3-ylidene) hydrazine carbothioamide were the most active members.

Experimental {#Sec7}
============

All melting points were determined on an electrothermal Gallenkamp apparatus. The IR spectra were measured on a Mattson 5000 FTIR spectrophotometer as potassium bromide discs. The ^1^H NMR and ^13^C NMR spectra were recorded as solutions in DMSO-*d* ~6~ on a Bruker WP spectrometer (300 MHz for ^1^H NMR and 75 MHz for ^13^C NMR) with the chemical shifts downfield from TMS as an internal standard. The mass spectra were recorded on Finnegan MAT 212 instrument (the ionizing voltage was 70 eV) at the Faculty of Science, Cairo University. Elemental analyses were carried out by the microanalytical unit of the Faculty of Science, Cairo University.

*3*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylideneamino)*-*2*-*thioxothiazolidin*-*4*-*one* (**2**, C~11~H~6~FN~3~O~2~S~2~) {#d29e1135}
------------------------------------------------------------------------------------------------------------------------

A mixture of 5-fluoroisatin (**1**, 0.01 mol) and 3-amino-2-thioxothiazolidin-4-one (0.01 mol) in 30 cm^3^ ethanol was heated under reflux for 1 h and left to cool. The solid product was filtered and recrystallized from ethanol to give **2** as brown crystals. Yield 85 %; m.p.: \>300 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,238 (NH), 1,700, 1,668 (C=O) cm^−1^; ^1^H NMR: *δ* = 5.80 (s, 2H, CH~2~), 6.94 (m, 1H, indole C~7~-H), 7.21 (m, 1H, indole C~6~-H), 7.44 (m, 1H, indole C~4~-H), 11.40 (s, 1H, NH) ppm; ^13^C NMR: *δ* = 33.7, 108.1, 112.5, 117.7, 121.8, 131.4, 138.9, 158.6, 163.1, 174.5, 177.3 ppm.

*2*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylideneamino)*-*N*-*\[3*-*(trifluoromethyl)phenyl\]benzamide* (**3**, C~22~H~13~F~4~N~3~O~2~) {#d29e1243}
-------------------------------------------------------------------------------------------------------------------------------------

A mixture of 5-fluoroisatin (**1**, 0.01 mol) and 2-amino-*N*-\[3-(trifluoromethyl)phenyl\]benzamide (0.01 mol) in 30 cm^3^ ethanol was heated under reflux for 1 h. The solution was concentrated, then left to cool. The solid product was filtered and recrystallized from toluene to give **3** as pale yellow solid. Yield 86 %; m.p.: 176--177 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,235, 3,192 (2NH), 1,665 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.13--7.76 (m, 11H, Ar--H), 9.12, 11.32 (2s, 2H, 2NH) ppm.

*N*′-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)arylsulfonohydrazides****5a***--***5c*** {#d29e1332}
-----------------------------------------------------------------------------------------

A mixture of hydrazone derivative **4** (0.01 mol), the appropriate sulfonyl chloride (namely methanesulfonyl chloride, benzenesulfonyl chloride, or 4-methylbenzenesulfonyl chloride) (0.01 mol), and 0.5 cm^3^ triethylamine in 30 cm^3^ dioxane was heated under reflux for 2 h. The reaction mixture was poured into crushed ice. The resulting precipitate was filtrated, dried, and crystallized from ethanol to afford **5a**--**5c**.

*N′*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)methanesulfonohydrazide* (**5a**, C~9~H~8~FN~3~O~3~S) {#d29e1377}
------------------------------------------------------------------------------------------------------

Brown crystals; yield 76 %; m.p.: 248--250 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,178, 3,106 (2NH), 1,660 (C=O) cm^−1^; ^1^H NMR: *δ* = 2.83 (s, 3H, CH~3~), 6.84, 6.95, 7.14 (3 m, 3H of indolyl), 10.68, 11.80 (2s, 2H, 2NH) ppm; ^13^C NMR: *δ* = 40.4 (CH~3~), 109.8 (C~4~-indolyl), 112.9 (C~7~-indolyl), 114.4 (C~6~-indolyl), 123.5 (C~4a~-indolyl), 136.6 (C~7a~-indolyl), 156.5 (C~5~-indolyl), 158.9 (C=N-indolyl), 162.9 (C=O-indolyl) ppm.

*N′*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)benzenesulfonohydrazide* (**5b**, C~14~H~10~FN~3~O~3~S) {#d29e1472}
--------------------------------------------------------------------------------------------------------

Brown crystals; yield 76 %; m.p.: 287--288 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,178, 3,106 (2NH), 1,660 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.40--7.96 (m, 8H, Ar--H), 9.56, 11.43 (2s, 2H, 2NH) ppm; ^13^C NMR: *δ* = 110.3, 112.3, 116.4, 118.6, 125.4 (2C), 127.5, 129.8 (2C), 136.7, 139.2, 154.4, 158.0, 161.0 ppm.

*4*-*Methyl*-*N′*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)benzenesulfonohydrazide* (**5c**, C~15~H~12~FN~3~O~3~S) {#d29e1542}
---------------------------------------------------------------------------------------------------------------------

Brown crystals; yield 75 %; m.p.: 198--199 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,178, 3,106 (2NH), 1,660 (C=O) cm^−1^; ^1^H NMR: *δ* = 2.36 (s, 3H, CH~3~), 7.40--7.98 (m, 7H, Ar--H), 10.96, 11.80 (2s, 2H, 2NH) ppm; ^13^C NMR: *δ* = 21.9 (CH~3~), 110.3, 112.3, 116.4, 118.6, 125.4 (2C), 127.5, 129.8 (2C), 136.7, 139.2, 154.4 (12 Ar--C), 158.0 (C=N of indolyl), 161.0 (C=O of indolyl) ppm; MS: *m*/*z* (%) = 333 (M^+^, 5.8), 299 (6.2), 271 (15.3), 257 (5.2), 179 (42.4), 151 (52.5), 136 (55.80), 108 (100).

*2,2,2*-*Trifluoro*-*N′*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)acetohydrazide* (**6**, C~10~H~5~F~4~N~3~O~2~) {#d29e1634}
-------------------------------------------------------------------------------------------------------------------

A mixture of the hydrazone **4** (0.01 mol) and 5 cm^3^ trifluoroacetic anhydride was stirred for 1 h at room temperature. The solution was concentrated under vacuum. The resultant precipitate was collected by filtration and crystallized from ethanol to give compound **6** as orange crystals. Yield 71 %; m.p.: \>300 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,255, 3,107 (2NH), 1,696, 1,661 (C=O) cm^−1^; ^1^H NMR: *δ* = 6.82 (m, 1H of indolyl), 7.36 (m, 1H of indolyl), 7.66 (m, 1H of indolyl), 11.46, 14.05 (2s, 2H, 2NH) ppm; ^13^C NMR: *δ* = 111.0 (C~4~-indolyl), 113.4 (C~7~-indolyl), 114.7 (C~6~-indolyl), 123.5 (C~4a~-indolyl), 136.5 (C~7a~-indolyl), 157.2 (C~5~-indolyl), 158.9 (C=N-indolyl), 163.2 (C=O-indolyl) ppm.

*Synthesis of thiosemicarbazone derivatives****7a***--***7f*** {#Sec4545}
--------------------------------------------------------------

A mixture of hydrazone **4** (0.01 mol) and the requisite isothiocyanate (namely methyl-, ethyl-, allyl-, *n*-butyl-, phenyl-, cyclohexylisothiocyanate) (0.01 mol) in 20 cm^3^ ethanol was heated under reflux for 1 h and left to cool. The resultant precipitate was collected and crystallized to give **7a**--**7f**.

### *2*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)*-*N*-*methylhydrazinecarbothioamide* (**7a**) {#d29e1768}

Yellow crystals; yield 87 %; m.p.: 271--273 °C (Ref. \[[@CR21]\] 271--274 °C).

### *N*-*Ethyl*-*2*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)hydrazinecarbothioamide* (**7b**) {#d29e1806}

Greenish yellow; yield 92 %; m.p.: 243--245 °C (Ref. \[[@CR21]\] 245--246 °C).

### *N*-*Allyl*-*2*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)hydrazinecarbothioamide* (**7c**) {#d29e1844}

Yellow crystals; yield 74 %; m.p.: 219--220 °C (Ref. \[[@CR21]\] 219--220 °C).

### *N*-*Butyl*-*2*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)hydrazinecarbothioamide* (**7d**) {#d29e1882}

Greenish yellow crystals; yield 81 %; m.p.: 211--212 °C (Ref. \[[@CR21]\] 211--212 °C).

### *2*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)*-*N*-*phenylhydrazinecarbothioamide* (**7e**) {#d29e1920}

Yellow crystals; yield 79 %; m.p.: 254--255 °C (Ref. \[[@CR21]\] 218 °C).

### *N*-*Cyclohexyl*-*2*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)hydrazinecarbothioamide* (**7f**) {#d29e1958}

Yellow crystals; yield 89 %; m.p.: 249--250 °C (Ref. \[[@CR21]\] 249--250 °C).

*Synthesis of thiazole derivatives****8a***--***8f*** {#Sec4598}
-----------------------------------------------------

A mixture of the thiosemicarbazide derivatives **7a**--**7f** (0.01 mol), chloroacetone (0.01 mol), and fused sodium acetate (0.02 mol) in 40 cm^3^ ethanol was heated under reflux for 5 h and left to cool. The obtained product was collected by filtration and recrystallized from the appropriate solvent to give **8a**--**8f**.

### *3*-*\[(3,4*-*Dimethylthiazol*-*2(3H)*-*ylidene)hydrazono\]*-*5*-*fluoroindolin*-*2*-*one* (**8a**, C~13~H~11~FN~4~OS) {#d29e2022}

Orange crystals from ethanol; yield 63 %; m.p.: 297--298 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,212 (NH), 2,986--2,876 (CH-aliph), 1,675 (C=O) cm^−1^; ^1^H NMR: *δ* = 1.76, 2.76 (2s, 6H, 2CH~3~), 5.85 (s, 1H, thiazole-H), 6.92 (m, 1H, indole), 7.32 (m, 1H, indole-H), 7.63 (m, 1H, indole-H), 10.41 (s, H, NH) ppm; ^13^C NMR: *δ* = 21.2, 31.3 (2 CH~3~), 95.3, 148.3, 162.2 (3C-thiazole), 117.4, 118.8, 122.5, 131.3, 135.3, 154.7 (6C-indole), 164.4 (C=N indole), 165.1 (indole C=O) ppm.

### *3*-*\[(3*-*Ethyl*-*4*-*methylthiazol*-*2(3H)*-*ylidene)hydrazono\]*-*5*-*fluoroindolin*-*2*-*one* (**8b**, C~14~H~13~FN~4~OS) {#d29e2102}

Brown crystals from ethanol; yield 65 %; m.p.: 276--277 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,218 (NH), 2,978--2,865 (CH-aliph), 1,668 (C=O) cm^−1^; ^1^H NMR: *δ* = 1.23 (t, 3H, ethyl-CH~3~), 1.78 (s, 3H, CH~3~), 3.68 (q, 2H,ethyl-CH~2~), 5.87 (s, 1H, thiazole), 6.89 (m, 1H, indole-H), 7.20 (m, 1H, indole-H), 7.68 (m, 1H, indole-H), 10.98 (s,1H, NH) ppm; ^13^C NMR: *δ* = 14.2 (ethyl-CH~3~), 22.3 (C-CH~3~), 40.1 (ethyl-CH~2~), 93.1, 157.3, 161.2 (3C-thiazole), 116.3, 119.2, 121.8, 125.4, 131.4, 152.6 (6C-indolyl), 159.9 (C=N indole), 163.5 (C=O indole) ppm.

### *3*-*\[(3*-*Allyl*-*4*-*methylthiazol*-*2(3H)*-*ylidene)hydrazono\]*-*5*-*fluoroindolin*-*2*-*one* (**8c**, C~15~H~13~FN~4~OS) {#d29e2201}

Brown crystals from ethanol; yield 61 %; m.p.: 278--279 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,232 (NH), 2,967--2,864 (CH-aliph), 1,676 (C=O) cm^−1^; ^1^H NMR: *δ* = 1.76 (s, 3H, CH~3~), 4.28 (t, 2H, allyl C1-H), 5.14 (d, 1H, allyl-H), 5.45 (d, 1H, allyl C~3~-H), 5.67--5.85 (m, 1H, allyl C~2~-H), 6.21(s, 1H, thiazol-H), 6.93 (m, 1H, indole-H), 7.19 (m, 1H, indole-H), 7.51 (m, 1H, indole-H), 11.20, (s, 1H, NH) ppm; ^13^C NMR: *δ* = 21.2 (C-CH~3~), 78.7, 120.2, 120.2 (3C-propenyl), 93.4, 157.7, 161.5 (3C-thiazole), 116.3, 119.4, 121.8, 126.3, 131.4, 155.6 (6C-indolyl), 159.9 (C=N indole), 163.5 (C=O indole) ppm.

### *3*-*\[(3*-*Butyl*-*4*-*methylthiazol*-*2(3H)*-*ylidene)hydrazono\]*-*5*-*fluoroindolin*-*2*-*one* (**8d**, C~16~H~17~FN~4~OS) {#d29e2293}

Red crystals from methanol; yield 66 %; m.p.: 248--250 °C: IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,232 (NH), 2,967--2,864 (CH-aliph), 1,676 (C=O) cm^−1^; ^1^H NMR: *δ* = 1.02 (t, 3H, butyl-CH~3~), 1.35--1.37 (m, 2H, butyl C~3~-H), 1.67 (m, 2H, butyl C~2~-H), 1.75 (s, 3H, CH~3~), 3.69 (q, 2H, butyl C~1~-H), 6.12 (s, 1H, thiazole-H), 6.67 (m, 1H, indole-H), 7.16 (m, 1H, indole-H), 7.64 (m, 1H, indole-H), 10.54 (s, 1H, NH) ppm; ^13^C NMR: *δ* = 14.2 (butyl CH~3~), 20.3 (butyl C~3~), 31.3 (butyl C~2~), 46.6 (butyl-C~1~), 23.2 (C-CH~3~), 98.5, 157.3, 164.3 (3C-thiazole), 112.4, 117.6, 121.8, 125.4, 131.3, 155.7 (6C-indole), 162.4 (C=N-indole), 163.4 (indole C=O) ppm; MS: *m*/*z* (%) = 332 (M^+^, 84.2), 276 (12.3), 262 (6.8), 247 (36.5), 177 (29.3), 162 (28.4), 134 (35.2), 94 (29.4), 55(100).

### *5*-*Fluoro*-*3*-*\[(4*-*methyl*-*3*-*phenylthiazol*-*2(3H)*-*ylidene)hydrazono\]indolin*-*2*-*one* (**8e**, C~18~H~13~FN~4~OS) {#d29e2414}

Red crystals from methanol; yield 62 %; m.p.: 265--267 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,236 (NH), 2,964--2,862 (CH-aliph), 1,667 (C=O) cm^−1^; ^1^H NMR: *δ* = 1.75 (s, 3H, CH~3~), 5.64 (s, 1H, CH-thiazole), 6.93--7.65 (m, 8H, Ar--H), 11.27 (s, 1H, NH) ppm; ^13^C NMR: *δ* = 22.3, 108.1, 112.5, 117.3 (2C), 118.4, 121.8, 125.7, 126.3 (2C), 129.4, 131.5, 138.9, 157.3, 158.7, 161.2, 165.2, 166.1 ppm.

### *3*-*\[(3*-*Cyclohexyl*-*4*-*methylthiazol*-*2(3H)*-*ylidene)hydrazono\]*-*5*-*fluoroindolin*-*2*-*one* (**8f**, C~18~H~19~FN~4~OS) {#d29e2497}

Orange crystals from methanol; yield 64 %; m.p.: 287--289 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,230 (NH), 2,960--2,868 (CH-aliph), 1,675 (C=O), 1,611, 1,602 (2 C=N) cm^−1^; ^1^H NMR: *δ* = 1.15, 1.28--1.35, 1.42--1.51, 1.64, 1.77, 1.92 (m, 10H, cycl), 1.78 (s, 3H, CH~3~), 4.18--4.21(m, 1H, cycl-C~1~-H), 5.89 (s, 1H, thiazole-H), 6.90 (m, 1H, indole-H), 7.32 (m,1H, indole-H), 7.76 (m, 1H, indole-H), 11.25 (s, 1H, indole NH) ppm; ^13^C NMR: *δ* = 25.3 (2C), 25.5, 31.9 (2C), 54.2 (6C-cycl), 117.7, 118.4, 121.8, 125.7, 131.5, 138.9, 158.7 (6C indole), 165.2 (C=N), 166.1 (indole C=O) ppm.

### *N1*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)thiocarbohydrazone* (**9**, C~9~H~8~FN~5~OS) {#d29e2583}

A mixture of isatin **1** (0.01 mol) and thiocarbohydrazide (0.01 mol) in 20 cm^3^ ethanol was heated under reflux for 0.5 h. The solid product so formed was filtered and recrystallized to give **9** as brown crystals. Yield 71 %; m.p.: \>300 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,270, 3,160, 3,106 (NH, NH~2~), 1,665 (C=O) cm^−1^; ^1^H NMR: *δ* = 2.51 (s, 1H, NH), 4.92 (bs, 2H, NH~2~),7.34, 7.42, 7.96 (3 m, 3H of indolyl), 10.40, 12.54 (2s, 2H, 2NH) ppm; ^13^C NMR: *δ* = 116.3, 118.3, 124.8, 127.5, 132.5, 157.7 (6C of indolyl), 161.0 (C=N of indolyl), 162.4 (C=O of indolyl), 179.4 (C=S) ppm.

*Synthesis of thiocarbohydrazones****10a***--***10e*** {#Sec11}
------------------------------------------------------

*Method A*: a solution of isatinthiocarbohydrazone **9** (0.01 mol) in 30 cm^3^ dioxane was treated with the requisite aldehyde (namely benzaldehyde, 4-fluorobenzaldehyde, 4-(dimethylamino)benzaldehyde, furan-2-carbaldehyde, or thiophene-2-carbaldehyde) (0.01 mol). The reaction mixture was heated under reflux for 1 h and left to cool. The solid product so formed was filtered and recrystallized to give **10a**--**10e**.

*Method B*: a solution of isatin **1** (0.01 mol) and the requisite thiocarbohydrazone derivative (0.01 mol) in ethanol was heated under reflux for 1 h. The solid product was filtered and recrystallized (m.p. and mixed m.p.).

### *N4*-*Benzylidene*-*N1*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)thiocarbohydrazone* (**10a**, C~16~H~12~FN~5~OS) {#d29e2700}

Orange crystals; yield 74 %; m.p.: 287--288 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,223, 3,160, 3,106 (NH), 1,665 (C=O) cm^−1^; ^1^H NMR: *δ* = 6.96 (m, 1H, indole-H), 7.22 (m, 1H, indole-H), 7.35 (m, 1H, indole-H), 7.48 (m, 3H, Ar--H), 7.48 (m, 2H, Ar--H), 8.34 (s, 1H, CH=N), 11.36, 12.44, 14.63 (3s, 3H, 3NH) ppm; ^13^C NMR: *δ* = 116.3, 118.3, 124.8, 125.4, 126.6, 127.5, 128.5, 129.5, 130.4, 131.4, 132.5, 157.7 (6C of indolyl + 6C-Ph), 159.6 (CH=N), 161.0 (C=N of indolyl), 162.8 (C=O of indolyl), 179.6 (C=S) ppm.

### *N1*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)*-*N4*-*(4*-*fluorobenzylidene)thiocarbohydrazone* (**10b**, C~16~H~11~F~2~N~5~OS) {#d29e2774}

Orange crystals; yield 75 %; m.p.: 265--266 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 33,412--3,110 (3NH), 1,697 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.22--7.86 (m, 7H, Ar--H), 8.54 (s, 1H, CH=N), 11.28, 12.76, 14.62 (3s, 3H, 3NH) ppm; ^13^C NMR: *δ* = 116.3, 118.3, 124.8, 125.4, 126.6, 127.5, 128.5, 129.5, 131.4, 132.5, 156.4, 157.7 (6C of indolyl + 6C-Ph), 159.6 (CH=N), 161.4 (C=N of indolyl), 162.8 (C=O of indolyl), 179.6 (C=S) ppm.

### *N4*-*(4*-*Dimethylaminobenzylidene)*-*N1*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)thiocarbohydrazone* (**10c**, C~18~H~17~FN~6~OS) {#d29e2854}

Reddish brown crystals; yield 70 %; m.p.: 277--278 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,243, 3,198, 3,161 (NH), 1,660 (C=O) cm^−1^; ^1^H NMR: *δ* = 2.88 (s, 6H, 2CH~3~), 7.18--7.76 (m, 7H, Ar--H), 8.11 (s, 1H, CH=N), 11.38, 12.60, 14.44 (3s, 3H, 3NH) ppm; ^13^C NMR: *δ* = 45.4, 45.4 (2CH~3~), 116.6, 118.4, 124.7, 125.6, 126.9, 127.8, 128.4, 129.5, 131.8, 132.2, 145.8, 157.9 (6C of indolyl + 6C-Ph), 159.6 (CH=N), 161.4 (C=N of indolyl), 162.8 (C=O of indolyl), 179.2 (C=S) ppm.

### *N1*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)*-*N4*-*(2*-*furylmethylene)thiocarbohydrazone* (**10d**, C~14~H~10~FN~5~O~2~S) {#d29e2937}

Brown crystals; yield 75 %; m.p.: 235--236 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,240, 3,212, 3,173 (NH), 1,668 (C=O) cm^−1^; ^1^H NMR: *δ* = 6.87--7.56 (m, 6H, Ar--H), 8.11 (s, 1H, CH=N), 11.22, 12.61, 14.41 (3s, 3H, 3NH) ppm; ^13^C NMR: *δ* = 111.3, 113.3, 116.6, 118.4, 125.6, 131.8, 144.2, 144.3, 145.8, 157.9 (6C of indolyl + 4C-furyl), 159.7 (CH=N), 161.6 (C=N of indolyl), 163.1 (C=O of indolyl), 179.2 (C=S) ppm.

### *N1*-*(5*-*Fluoro*-*2*-*oxoindolin*-*3*-*ylidene)*-*N4*-*(2*-*thienylmethylene)thiocarbohydrazone* (**10e**, C~14~H~10~FN~5~O~2~S~2~) {#d29e3017}

Brown crystals; yield 74 %; m.p.: 282--284 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,248, 3,223, 3,190 (NH), 1,665 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.18--7.98 (m, 6H, Ar--H), 8.54 (s, 1H, CH=N), 11.67, 12.43, 14.00 (3s, 3H, 3NH) ppm; ^13^C NMR: *δ* = 116.6, 118.4, 123.3, 125.6, 126.1, 126.4, 127.6, 127.8, 134.2, 157.9 (10C of indolyl), 159.7 (CH=N), 161.6 (C=N of indolyl), 163.4 (C=O of indolyl), 179.4 (C=S) ppm.

### *N1,N4*-*Bis(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)thiocarbohydrazone* (**11**, C~17~H~10~F~2~N~6~O~2~S) {#d29e3100}

A mixture the thiocarbohydrazone **9** (0.01 mol) and 5-fluoroisatin (0.01 mol) in 20 cm^3^ dioxane was heated under reflux for 2 h. The solid product so formed was filtered and recrystallized from dioxane to give **11** as red crystals. Yield 68 %; m.p.: \>300 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,256, 3,212, 3,187 (NH), 1,667 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.10--7.64 (m, 6H, indole-H), 10.76, 11.54, 12.23, 14.11 (4s, 4H, 4NH) ppm; ^13^C NMR: *δ* = 116.6, 116.7, 118.4, 118.7, 122.4, 123.3, 125.4, 126.1, 134.1, 134.2, 156.5, 157.9 (12C of indolyl), 161.6, 161.9 (2C=N of indolyl), 163.1, 163.4 (2C=O of indolyl), 178.1 (C=S) ppm; MS: *m*/*z* (%) = 400 (M^+^, 12.6), 373 (32.26), 221 (36.4), 179 (86.4), 164 (46.8), 136 (99.28), 108 (100), 94 (48.24), 81 (52.35).

### *2,2,2*-*Trifluoro*-*N′*-*(2*-*(5*-*fluoro*-*2*-*oxoindolin*-*3*-*ylidene)hydrazinecarbonothioyl)acetohydrazide* (**12**, C~11~H~7~F~4~N~5~O~2~S) {#d29e3193}

A solution of the thiocarbohydrazone **9** (0.01 mol) in 10 cm^3^ trifluoroacetic anhydride was stirred at room temperature for 1 h. The solution was concentrated under vacuum. The solid product so formed was filtered off, washed with ethanol, dried well, and recrystallized to give **12** as red crystals. Yield 79 %; m.p.: \>300 °C; IR: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$ \overline{\nu } $$\end{document}$ = 3,340--3,210 (br-NH), 1,697, 1,670 (C=O) cm^−1^; ^1^H NMR: *δ* = 7.18--7.56 (3 m, 3H, indole-H), 10.87, 11.45, 12.12, 14.34 (4s, 4H, 4NH) ppm; ^13^C NMR: *δ* = 116.6, 118.4, 123.3, 125.6, 127.8, 134.2, 157.9 (6C of indolyl + CF~3~), 161.6 (C=N of indolyl), 163.4 (C=O of indolyl), 169.7 (CO-CF~3~), 179.4 (C=S) ppm.

Antiviral and cytotoxicity assays {#Sec8}
---------------------------------

Vero clone CCL-81 cells were grown in 199 E-Hepes buffer growth medium supplemented with 10 % inactivated fetal calf serum, 5 mM HEPES buffer, and antibiotics (100 U of penicillin/cm^3^, 100 g of streptomycin/cm^3^) at 37 °C and incubated in 5 % CO~2~ atmosphere.

### Cytotoxicity assay {#Sec9}

Organic compounds (50 μmol) were dissolved in 2 cm^3^ phosphate buffer saline, pH 7.2 ± 0.2. Test materials were filtered through 0.2-μm membranes using Millipore disposable syringe filters. The cytotoxicity assay of the tested organic compounds was performed according to the previous reports \[[@CR23]\], whereby sterile filtrated organic test materials were twofold serially diluted in MEM and added to precultured Vero cells. A negative cell control was included. Plates were incubated at 37 °C for 24 h. Cell culture-treated plates were microscopically examined using an inverted microscope for detection of cellular changes. The test compounds treatment medium was discarded. Plates were washed using PBS. Cell viability was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The cytotoxicity of each compound was expressed as the 50 % cytotoxic concentration (CC~50~), which is the concentration required to reduce cell viability to 50 % of the control.

### Antiviral activity {#Sec10}

Antiviral activity of the synthetic compounds and interferon against VSV isolate was determined according to the method reported by Shinji \[[@CR22]\], whereby nontoxic concentrations of test chemical compounds and rh-IFN (10 IU/0.1 cm^3^) as a positive control were used for the treatment of precultured Vero cells for 24 h at 0.1 cm^3^/well. One plate was maintained and left untreated for viral control titration. A virus infectivity titer was determined according to a reported method \[[@CR24]\]; VSV was tenfold serially diluted in 199 E-Hepes buffer (10^−1^--10^−8^). Each dilution was dispensed as 100 mm^3^/well onto preculture Vero cells. Plates were inoculated using 10 CCID~50~ of VSV isolate tested. Plates were incubated at 37 °C. Seven days post infection the 50 % end point (CCID~50~) was determined. Antiviral activity was determined by subtracting the VSV mean titer in the treated and non-treated cell titers. The difference between both titers refers to the antiviral activity.
